- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07632755
Validation of a Remediation Method for Memory Impairments Through Motor Encoding in Patients With Alzheimer's Disease (ADACT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Céline BORD, MD
- Phone Number: +33 (0)4 77 82 88 82
- Email: celine.borg@chu-st-etienne.fr
Study Contact Backup
- Name: Céline LECLERCQ TRAUTVETTER, CDP
- Phone Number: +33 (0)4 77 82 94 27
- Email: Celine.LECLERCQTRAUTVETTER@chu-stetienne.fr
Study Locations
-
-
-
Grenoble, France, 38700
- CHU Grenoble
-
Principal Investigator:
- Mathilde SAUVEE, MD
-
Sub-Investigator:
- Olivier MOREAUD, MD
-
Saint-Etienne, France, 42055
- Chu de Saint Etienne
-
Principal Investigator:
- Céline BORG, MD
-
Villeurbanne, France, 69100
- HLC, Hôpital des Charpennes
-
Principal Investigator:
- Isabelle ROUCH, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patient group: Diagnosis of Alzheimer's disease made by one of the consulting physicians-a neurologist and/or geriatrician (Dubois et al., 2014)-at the early stage, presenting with mild memory impairment of which the patient has been informed
- MMSE score of 21 or higher
Control group: individuals without a diagnosis of Alzheimer's disease, but meeting the other criteria listed below
- Enrollment in a social security program
- Age 60 or older
- French as a native language
- Consent to participate
Exclusion Criteria:
- Uncorrected visual or hearing impairments
- Language or motor impairments
- Delirium or psychosis.
- Medical treatment affecting vision, language, or motor skills (or participation in a study involving a drug or device that influences cognition).
- Refusal to participate.
- Inability to communicate
- Persons deprived of liberty by a judicial or administrative decision and adults subject to a legal protection measure or unable to express their consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control condition
|
Reading a sentence aloud and the participant is asked to freely recall, without delay and without cues, all the sentences presented in the block.
The number of correctly recalled sentences is recorded.
Other Names:
|
|
Experimental: Motor imagery intervention
|
Following the reading of each sentence, the participant is instructed to mentally simulate performing the action described in the sentence.
And the participant is asked to freely recall, without delay and without cues, all the sentences presented in the block.
The number of correctly recalled sentences is recorded.
Other Names:
|
|
Experimental: Real action
|
After reading the sentence, the participant pantomimes the action described and The participant is asked to freely recall, without delay and without cues, all the sentences presented in the block.
The number of correctly recalled sentences is recorded.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Free recall score
Time Frame: at 1 week
|
The free recall score corresponds to the number of sentences spontaneously retrieved by participants after learning, measuring free retrieval ability.
|
at 1 week
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25CH313
- ANSM (Other Identifier: 2025-A00293-46)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healhty
-
Haisco Pharmaceutical Group Co., Ltd.Recruiting
-
Hasanuddin UniversityDSM-Firmenich AGActive, not recruiting
-
Universitas PadjadjaranCompleted
-
Mersin UniversityCompletedHealhtyTurkey (Türkiye)
-
Mylan Pharmaceuticals IncCompleted
-
Shanghai WD Pharmaceutical Co., Ltd.Shanghai Xuhui Central Hospital; BalGenSource Medical Technology Co. Ltd.; Shanghai... and other collaboratorsRecruiting
-
Princess Nourah Bint Abdulrahman UniversityCompleted
-
bekir tokayUşak UniversityCompleted
-
Nord UniversityCompleted
Clinical Trials on Control condition
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA); Florida Institute for Human and Machine...CompletedPhysical Activity | Aging | Social IsolationUnited States
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA)Completed
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedColorectal Cancer
-
Duke UniversityCompletedNicotine DependenceUnited States
-
University of Colorado, BoulderNational Institute of Mental Health (NIMH)CompletedPhysical Activity | Affect
-
National Taiwan Normal UniversityCompletedMental FatigueTaiwan
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); University of StellenboschActive, not recruitingDepression | Malnutrition | HIV | Partner Violence | Alcohol Use/AbuseSouth Africa
-
Brandeis UniversityCompletedSedentary Behavior | InactivityUnited States
-
Texas Christian UniversityCompletedEndothelial DysfunctionUnited States